Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/4D-PHARMA-PLC-56171591/news/Ergebnisse-der-klinischen-Phase-II-Studie-mit-Blautix-von-4D-pharma-in-Alimentary-Pharmacology-The-42359353/?utm_source=whatsapp&utm_medium=social&utm_campaign=share